4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-460801
Principal Financial Officer bought 10,000 shares at $0.65 ($6,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alfieri Michael Principal Financial Officer | 2026-11-11 | Purchase | +10,000 | $0.65 | $6,500 | 17,500 | D |
| Open-market purchases · 10,000 sh · avg $0.65 · $6,500 | |||||||
Loading xslF345X06/ownership.xml…